Can peptides fix a slow metabolism?

A 33-year-old high school football and basketball referee posted on r/peptides this month describing four years of unexplained weight gain: 27 pounds added over the last two years despite what he says is an unchanged diet and exercise routine^[1]. He asked whether peptides could help. The honest answer starts with a different question. Has anyone tested his thyroid, his fasting glucose, and his testosterone? Incretin peptides such as semaglutide and tirzepatide are real prescription medicines with strong trial evidence behind them, but neither is licensed to fix a slowed metabolism, and neither replaces finding out why the weight started climbing in the first place.

What incretin peptides actually do

Semaglutide (sold as Ozempic, Wegovy and Rybelsus) and tirzepatide (sold as Mounjaro and Zepbound) belong to a drug class called incretin mimetics. They copy the action of gut hormones released after eating: GLP-1 for semaglutide, and both GLP-1 and GIP for tirzepatide, which acts on two receptors instead of one. The FDA labeling for Wegovy describes the mechanism directly: the drug works by suppressing appetite and slowing gastric emptying, so a person feels full sooner and stays full longer^[2]. That is an appetite effect, not a metabolic-rate effect. The drug does not raise how many calories the body burns at rest. It changes how much a person wants to eat.

The trial data support that framing. In Study 1 of the Wegovy clinical program, the FDA label reports a mean 14.9% body-weight reduction at 68 weeks on semaglutide 2.4 mg, versus 2.4% on placebo, in adults following the same reduced-calorie diet and exercise plan^[2]. Across the EU and EEA, the European Medicines Agency authorises Wegovy for the identical use, and it is prescription-only in every country PeptideMethods covers^[3]. No incretin peptide is sold over the counter, and none is marketed as a general metabolism booster.

Why 'nothing changed' is the detail worth chasing

Steady weight gain in someone who trains as much as a sports official's season demands, without a diet change, is a pattern worth a work-up before it becomes a prescription question. The National Institute of Diabetes and Digestive and Kidney Diseases lists weight gain among the common symptoms of an underactive thyroid, alongside fatigue, cold intolerance and dry skin, and it notes that thyroid blood tests confirm or rule the condition out^[4]. A simple panel answers a question that no peptide can.

Insulin resistance is the other common, testable explanation. The same agency describes insulin resistance as a state where the body stops responding normally to insulin, which can raise blood glucose and drive weight gain, and it is diagnosed with a fasting glucose test, an A1C test, or an oral glucose tolerance test^[5]. Low testosterone, sleep apnea and a handful of common prescription drugs round out the usual list clinicians check before calling a case unexplained. Each of those has a blood test or a sleep study attached to it, not a peptide protocol.

What incretin peptides are actually approved to treat

Even once other causes are ruled out, semaglutide and tirzepatide are not open-label answers for a metabolism that feels off. The Wegovy label restricts use to adults with a BMI of 30 or higher, or a BMI of 27 or higher plus a weight-related condition such as high blood pressure or type-2 diabetes^[2]. Tirzepatide, sold as Mounjaro for type-2 diabetes and Zepbound for weight management, is licensed on comparable BMI and comorbidity thresholds by the FDA, the EMA and the MHRA. Both drugs require an ongoing prescription, not a single self-directed purchase.

Physician Spencer Nadolsky covered the same mechanism on Sigma Nutrition Radio, framing GLP-1 drugs as an appetite tool rather than a metabolism fix: less hunger, slower gastric emptying, and weight loss that follows from eating less^[6]. Vials sold online as research-grade semaglutide or tirzepatide are not the same product as the branded pens. They sit outside every regulatory framework this site tracks, and independent testing of that grey market has repeatedly found purity and identity problems. That route answers nothing about what caused the weight gain, and it adds a new set of risks on top of the old question.

What this means if you've gained weight for no clear reason

If your habits genuinely have not changed and the scale keeps moving anyway, start with a clinician and a blood panel: thyroid function, fasting glucose or A1C, and testosterone are the three cheapest, fastest answers, and they cost far less than a month of any peptide. If those come back clear and a BMI or comorbidity threshold is met, semaglutide or tirzepatide are legitimate, well-studied options to raise with a prescriber, alongside the regulatory detail on semaglutide for how each country licenses it. What neither drug does is stand in for the diagnosis. That conversation belongs with a clinician who can actually run the tests.